These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 15476238

  • 1. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J, Tremblay M, Clément I, Raymond Y, Senécal JL.
    Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
    [Abstract] [Full Text] [Related]

  • 2. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients.
    Hénault J, Robitaille G, Senécal JL, Raymond Y.
    Arthritis Rheum; 2006 Mar; 54(3):963-73. PubMed ID: 16508979
    [Abstract] [Full Text] [Related]

  • 3. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
    Chizzolini C, Raschi E, Rezzonico R, Testoni C, Mallone R, Gabrielli A, Facchini A, Del Papa N, Borghi MO, Dayer JM, Meroni PL.
    Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
    [Abstract] [Full Text] [Related]

  • 4. Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway.
    Ronda N, Gatti R, Giacosa R, Raschi E, Testoni C, Meroni PL, Buzio C, Orlandini G.
    Arthritis Rheum; 2002 Jun; 46(6):1595-601. PubMed ID: 12115191
    [Abstract] [Full Text] [Related]

  • 5. Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts.
    Fineschi S, Cozzi F, Burger D, Dayer JM, Meroni PL, Chizzolini C.
    Rheumatology (Oxford); 2007 Dec; 46(12):1779-85. PubMed ID: 17982166
    [Abstract] [Full Text] [Related]

  • 6. Heparin inhibits the interaction of DNA topoisomerase I/anti-topoisomerase I immune complexes with heparan sulfate on dermal fibroblasts.
    Arcand J, Robitaille G, Koenig M, Senécal JL, Raymond Y.
    Arthritis Rheum; 2012 May; 64(5):1632-41. PubMed ID: 22095242
    [Abstract] [Full Text] [Related]

  • 7. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
    Hayakawa I, Hasegawa M, Takehara K, Sato S.
    Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
    [Abstract] [Full Text] [Related]

  • 8. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
    Hayakawa I, Hasegawa M, Takehara K, Sato S.
    Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
    [Abstract] [Full Text] [Related]

  • 9. IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients.
    García de la Peña-Lefebvre P, Chanseaud Y, Tamby MC, Reinbolt J, Batteux F, Allanore Y, Kahan A, Meyer O, Benveniste O, Boyer O, Guillevin L, Boissier MC, Mouthon L.
    Clin Immunol; 2004 Jun; 111(3):241-51. PubMed ID: 15183145
    [Abstract] [Full Text] [Related]

  • 10. An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera.
    Kuwana M, Kaburaki J, Medsger TA, Wright TM.
    Arthritis Rheum; 1999 Jun; 42(6):1179-88. PubMed ID: 10366110
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
    Simon D, Czömpöly T, Berki T, Minier T, Peti A, Tóth E, Czirják L, Németh P.
    Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
    [Abstract] [Full Text] [Related]

  • 14. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y.
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [Abstract] [Full Text] [Related]

  • 15. Anti-topoisomerase I autoantibodies in systemic sclerosis.
    Czömpöly T, Simon D, Czirják L, Németh P.
    Autoimmun Rev; 2009 Jul; 8(8):692-6. PubMed ID: 19393194
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Involvement of lysosomal cathepsins in the cleavage of DNA topoisomerase I during necrotic cell death.
    Pacheco FJ, Servin J, Dang D, Kim J, Molinaro C, Daniels T, Brown-Bryan TA, Imoto-Egami M, Casiano CA.
    Arthritis Rheum; 2005 Jul; 52(7):2133-45. PubMed ID: 15986368
    [Abstract] [Full Text] [Related]

  • 18. T and B cell collaboration is essential for the autoantibody response to DNA topoisomerase I in systemic sclerosis.
    Kuwana M, Medsger TA, Wright TM.
    J Immunol; 1995 Sep 01; 155(5):2703-14. PubMed ID: 7650398
    [Abstract] [Full Text] [Related]

  • 19. Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension.
    Tamby MC, Chanseaud Y, Humbert M, Fermanian J, Guilpain P, Garcia-de-la-Peña-Lefebvre P, Brunet S, Servettaz A, Weill B, Simonneau G, Guillevin L, Boissier MC, Mouthon L.
    Thorax; 2005 Sep 01; 60(9):765-72. PubMed ID: 16135682
    [Abstract] [Full Text] [Related]

  • 20. Recruitment of topoisomerase I (Scl-70) to nucleoplasmic proteasomes in response to xenobiotics suggests a role for altered antigen processing in scleroderma.
    Chen M, Dittmann A, Kuhn A, Ruzicka T, von Mikecz A.
    Arthritis Rheum; 2005 Mar 01; 52(3):877-84. PubMed ID: 15751092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.